Louise Lanoue

Dr. Louise Lanoue

orcid

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 January 2008 in Biological Trace Element Research
Verified
Journal Article
Closed access
PDF file
VLVeronica Lopez
Veronica Lopez
CKCarl L. Keen
Carl L. Keen
LLLouise Lanoue
Louise Lanoue

1 January 2010 in Experimental Biology and Medicine
Verified
Journal Article
Closed access
LLLouise Lanoue
Louise Lanoue
KGKerri K Green
Kerri K Green
CKCatherine Kwik-Uribe
Catherine Kwik-Uribe
CKCarl Keen
Carl Keen
There is cumulative strong evidence that diets rich in flavanols can provide certain positive health benefits, particularly with respect to the cardiovascular system. Consequently, it has been suggested that increasing one's dietary intake of flavanols may be of benefit. Complicating this idea, there are reports that high intakes of certain flavonoids during pregnancy are associated with an increased risk for acute infant leukemia due to a poison effect of select polyphenolic compounds on DNA topoisomerase (topo) II activity that promotes aberrant chromosomal translocations. In the current study, we characterized the effects of select flavanols (epicatechin and catechin monomers), and select flavanol dimers and longer oligomers, on topo II activity, and on cellular toxicity in vitro. In contrast to the chemotherapeutic drug etoposide (VP16) and the flavonol quercetin, which strongly inhibited topo II activity and increased the formation of cleavage complexes demonstrating a poison effect, the flavanols epicatechin and catechin had little effect on topo II enzyme activity. Accordingly, several fold greater concentrations of the flavanols were required to achieve cellular toxicity similar to that of quercetin and VP16 in cultures of myeloid and lymphoid cells. Low cellular toxicity and limited topo II inhibition were also observed with a procyanidin-rich cocoa extract. Of all the flavanols tested, the dimers (B2, B5 and a mix of both) exerted the greatest inhibition of topo II and inhibited cellular proliferation rates at concentrations similar to quercetin. However, in contrast to quercetin, the dimers did not function as topo II poisons. Collectively, our in vitro data show that cocoa-derived flavanols have limited effects on topo II activity and cellular proliferation in cancer cell lines. We predict that these compounds are likely to have limited leukemogenic potential at physiological concentrations.

1 January 2015 in Toxicology Reports
Verified
Journal Article
Open access
MLMary N.R. Lesser
Mary N.R. Lesser
CKCarl Keen
Carl Keen
LLLouise Lanoue
Louise Lanoue
Maternal nutrition can have a significant effect on developmental processes during pregnancy and lactation. While certain flavonoids have been postulated to be beneficial for health, little is known about the effects of ingestion during pregnancy and lactation on the mother and progeny. We report on the effects of maternal consumption of high levels of certain flavonoids on reproductive and developmental outcomes in a mouse model. C57BL/6J female mice were fed a control diet (CT), the CT diet supplemented with 1% or 2% of a mix of epicatechin and catechin (EC1, EC2), or rutin (RU1, RU2) prior to, during pregnancy, and lactation. A subset of dams was killed on gestation day (GD) 18.5 to evaluate fetal outcomes and the remainder was allowed to deliver to evaluate offspring. Maternal food intake, body and tissue weight did not differ among groups. The number of resorptions, implantations, litter size, postnatal survival, body weight, and skeletal development were also similar. Alterations in maternal and offspring liver mineral concentrations were observed. The current results indicate that consumption of high amounts of epicatechin, catechin, and rutin during gestation and lactation is not associated with any marked developmental effects, although changes in liver mineral concentrations were noted.

13 October 2022 in Genome Medicine
Verified
Journal Article
Open access
PDF file
PCPilar Cacheiro
Pilar Cacheiro
CWCarl Henrik Westerberg
Carl Henrik Westerberg
JMJesse Mager
Jesse Mager
MDMary E. Dickinson
Mary E. Dickinson
LNLauryl Nutter
Lauryl Nutter
DSDamian Smedley
Damian Smedley
Background: The diagnostic rate of Mendelian disorders in sequencing studies continues to increase, along with the pace of novel disease gene discovery. However, variant interpretation in novel genes not currently associated with disease is particularly challenging and strategies combining gene functional evidence with approaches that evaluate the phenotypic similarities between patients and model organisms have proven successful. A full spectrum of intolerance to loss-of-function variation has been previously described, providing evidence that gene essentiality should not be considered as a simple and fixed binary property.Methods: Here we further dissected this spectrum by assessing the embryonic stage at which homozygous loss-of-function results in lethality in mice from the International Mouse Phenotyping Consortium, classifying the set of lethal genes into one of three windows of lethality: early, mid, or late gestation lethal. We studied the correlation between these windows of lethality and various gene features including expression across development, paralogy and constraint metrics together with human disease phenotypes. We explored a gene similarity approach for novel gene discovery and investigated unsolved cases from the 100,000 Genomes Project.Results: We found that genes in the early gestation lethal category have distinct characteristics and are enriched for genes linked with recessive forms of inherited metabolic disease. We identified several genes sharing multiple features with known biallelic forms of inborn errors of the metabolism and found signs of enrichment of biallelic predicted pathogenic variants among early gestation lethal genes in patients recruited under this disease category. We highlight two novel gene candidates with phenotypic overlap between the patients and the mouse knockouts.Conclusions: Information on the developmental period at which embryonic lethality occurs in the knockout mouse may be used for novel disease gene discovery that helps to prioritise variants in unsolved rare disease cases.

25 October 2006 in Birth Defects Research Part B: Developmental and Reproductive Toxicology
Verified
Journal Article
Closed access
PDF file
SYSoo Jin Yang
Soo Jin Yang
JUJanet Y. Uriu-Adams
Janet Y. Uriu-Adams
CKCarl L. Keen
Carl L. Keen
RRRobert B. Rucker
Robert B. Rucker
LLLouise Lanoue
Louise Lanoue

16 February 2015 in Birth Defects Research Part B: Developmental and Reproductive Toxicology
Verified
Journal Article
Closed access
PDF file
HYHsunhui Yang
Hsunhui Yang
CKCarl L. Keen
Carl L. Keen
LLLouise Lanoue
Louise Lanoue